For the financial year ending 30/06/2026 

 

This statement is made pursuant to section 54 of the UK Modern Slavery Act 2015 and sets out the actions taken by Hexarad to prevent modern slavery and human trafficking in our business operations and supply chains. 

 

About Hexarad 

Hexarad is a UK-based Health tech company, supporting NHS trusts and private healthcare providers with high-quality, efficient radiology reporting and workflow solutions. Our services are delivered through a network of consultant radiologists, cardiologists and reporting radiographers, supported by clinical systems, clinical governance, and operational teams. 

 

Hexarad is headquartered in the UK, but works with reporting staff located across the globe.  In addition to the NHS and private organisations we support in the UK, we also provide services in the Republic of Ireland and The Kingdom of Saudi Arabia. 

​

Our Commitment 

We are committed to acting ethically and with integrity in all aspects of our business. Hexarad has a zero-tolerance approach to slavery, servitude, forced labour, and human trafficking. We expect all our suppliers, contractors, and business partners to uphold the same high standards. Hexarad has/will incorporate the statement as required by law in both its website and its annual report 

 

Our Supply Chains 

Our supply chains primarily consist of: 

• Professional services (reporting workforce, operational staffing governance and advisory services) 

• IT infrastructure, software, and cloud hosting providers 

• Business services (legal, finance) 

 

We assess the risk of modern slavery within our direct operations as low, but we recognise that risks may exist in extended supply chains, particularly in IT and outsourced services. 

 

Policies and Procedures 

To uphold our commitment, we have implemented the following: 

• Ethical Procurement Policy 

• Freedom to Speak Up (Whistleblowing) Policy allowing staff and contractors to raise concerns confidentially. 

• Safeguarding Adults and Children Policies 

• Recruitment Policies for clinical and non-clinical staff ensuring transparent and lawful engagement of staff and contractors. 

• Bribery and Corruption Policy 

• Bullying and Harassment Policy 

• Due Diligence Checks for onboarding suppliers and partners, including compliance with relevant UK legislation. 

 

Responsibilities  

Hexarad Executive Team: Has overall responsibility for ensuring this Policy complies with Hexarad’s legal and ethical obligations, and that all those under its control comply with it.  

Hexarad Chief Executive officer: Has primary responsibility for implementing this Policy with respect to all staff and to vendors 

 

Risk Assessment and Due Diligence 

We mitigate modern slavery risks by: 

• Conducting proportionate due diligence on new suppliers and partners. 

• Reviewing contracts to include modern slavery compliance obligations. 

• Monitoring higher-risk categories (e.g. IT services and recruitment agencies). 

• Ensuring all our supplier’s values align with ours. 

 

Regulatory Requirements 

Hexarad requires all of its vendors, contractors and third party business partners to comply with all laws pertaining to Modern Slavery. Third parties subject to this Policy are expected to take all reasonable means necessary to ensure compliance including but not limited to ensuring their employees receive training on the requirements of this policy.  

 

Training and Awareness 

We ensure that our management and procurement teams are familiar with the requirements of the Modern Slavery Act 2015 and our internal policies. 

As part of our commitment to continuous improvement, we will explore the introduction of proportionate training and awareness materials for relevant staff and contractors in the coming year. 

 

Continuous Improvement 

In the next reporting period, Hexarad will: 

Strengthen supplier monitoring and compliance checks. 

Expand staff training on ethical supply chain management. 

 

References  

Modern Day Slavery Act 2015 

https://www.legislation.gov.uk/ukpga/2015/30/contents/enacted 

 

Approval 

This statement has been approved by the Board of Directors of Hexarad on 12/11/2025 and is signed on their behalf by: 

 

Dr Jaymin Patel 

 
Chief Operating Officer 
Hexarad